Meeting
2023 ASCO Annual Meeting
Clinical course and native antibody development after COVID-19 infection in 50 pediatric oncology patients.
Authors
Maeve Smart
Dana-Farber Cancer Institute, Boston, MA
Maeve Smart , Olivia Puopolo , Matthew R Chang , Hanzhong Ke , Wayne A Marasco , Catherine R. Marinac , Jennifer W. Mack , Allison Frances O'Neill , Katherine A. Janeway , Suzanne J. Forrest
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Symptom Management/Supportive Care/Palliative Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10063)
DOI
10.1200/JCO.2023.41.16_suppl.10063
Abstract #
10063
Poster Bd #
369
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Longitudinal immunological responses of COVID-19 vaccination in patients with solid tumors on active treatment: A pilot study.
First Author: Lifen Cao
Poster
2022 ASCO Annual Meeting
Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer.
First Author: Amy Body
Poster
2022 ASCO Genitourinary Cancers Symposium
The effect of anti-cancer therapy on immunological response to COVID-19 vaccination.
First Author: Francesca Jackson-Spence
Poster
2021 ASCO Annual Meeting
Patterns in cancer management changes for patients with COVID-19 in northern California.
First Author: Michael Glover